Interleukin-5 inhibition of biliary cell chloride currents and bile flow

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 4 43-4, 2001, Pages

  McGill, James M ^a,d   Yen, Margaret S ^a   Cummings, Oscar W ^a   Alpini, Gianfranco ^b,c   Lesage, Gene ^b   Pollok, Karen E ^a   Miller, Barbara ^a   Engle, Steven K ^a   Stansfield, Ann P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c Ctrl Texas Vet Health Care System   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Chloride channel; Cholestatic liver disease; Patch clamp recording

Indexed keywords

ADENOSINE 5' (N ETHYLCARBOXAMIDE); INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; MESSENGER RNA; SECRETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; BILE FLOW; BILIARY CIRRHOSIS; CANCER CELL CULTURE; CELL IMMORTALIZATION; CHLORIDE CURRENT; CHOLESTASIS; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; HUMAN CELL; LIVER INJURY; LIVER PARENCHYMA; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035012065     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.4.g738     Document Type: Article

References (68)

1. Adachi T and Alam R. The mechanism of IL-5 signal transduction. Am J Physiol Cell Physlol 275: C623-C633, 1998.
2. Akutsu I, Kojima T, Kariyone A, Fukuda T, Makino S, and Takatsu K. Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways. Immunol Lett 45: 109-116, 1995.
3. Alpini G, Glaser S, Robertson W, Rodgers RED, Phinizy JL, Lasater J, and LeSage GD. Large but not small intrahepatic bile ducts are involved in secretin-regulated ductal bile secretion. Am J Physiol Gastrointest Liver Physiol 272: G1064-G1074, 1997.
4. Alpini G, Lenzi R, Zhai WR, Liu MH, Slott PA, Paronetto F, and Tavoloni N. Isolation of a nonparenchymal liver cell fraction enriched in cells with biliary epithelial phenotypes. Gastroenterology 97: 1248-1260, 1989.
5. Alpini G, Lenzi R, Zhai WR, Slott PA, Liu MH, Sarkozi L, and Tavoloni N. Bile secretory function of intrahepatic biliary epithelium in the rat. Am J Physiol Gastrointest Liver Physiol 257: G124-G133, 1989.
6. Alpini G, Phillips JO, and LaRusso NF. The biology of biliary epithelia. In: The Liver: Biology and Pathobiology, edited by Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, and Shafritz DA. New York: Raven, 1994, p. 623-653.
7. Alpini G, Roberts S, Kuntz SM, Ueno Y, Gubba S, Podila PV, LeSage G, and LaRusso NF. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 110: 1636-1643, 1996.
8. Alpini G, Ulrich C, Roberts S, Phillips JO, Ueno Y, Podila PV, Colegio O, LeSage GD, Miller LJ, and LaRusso NF. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol Gastrointest Liver Physiol 272: G289-G297, 1997.
9. + transport in human biliary cell lines. Gastroenterology 104: 1796-1805, 1993.
10. Berg PA, Klein R, and Röcken M. Cytokines in primary biliary cirrhosis. Semin Liver Dis 17: 115-123, 1997.
11. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
12. Clarke LL, Grubb BR, Gabriel SE, Smithies O, Koller BH, and Boucher RC. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science 257: 1125-1128, 1992.
13. Coffman RL, Seymour BWP, Hudak S, Jackson J, and Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245: 308-310, 1989.
14. Cohn JA, Strong TA, Picciotto MA, Nairn AC, Collins FS, Francis A, and Fitz JG. Localization of CFTR in human bile duct epithelial cells. Gastroenterology 105: 1857-1864, 1993.
15. Colombo C, Battezzati PM, and Podda M. Hepatobiliary disease in cystic fibrosis. Semin Liver Dis 14: 259-269, 1994.
16. Crawford JM and Boyer JL. Clinicopathology conferences: inflammation-induced cholestasis. Hepatology 28: 253-260, 1998.
17. Desreumaux P, Bloget F, Seguy D, Capron M, Cortot A, Colombel JF, and Janin A. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology 110: 768-774, 1996.
18. Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, Capron M, and Colombel JF. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut 37: 242-246, 1995.
19. 2B receptors. Pharmacol Rev 49: 381-402, 1997.
20. Fitz JG, Basavappa S, McGill J, Melhus O, and Cohn JA. Regulation of membrane chloride currents in rat bile duct epithelial cells. J Clin Invest 91: 319-328, 1993.
21. Frizzell RA, Rechkememer G, and Shoemaker RL. Altered regulation of airway epithelial cell chloride channels in cystic fibrosis. Science 233: 558-560, 1986.
22. Gabriel SE, Brigman KN, Koller BH, Boucher RC, and Stutts MJ. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266: 107-109, 1994.
23. Gaweco AS, Otto G, Otto HF, Geisse T, and Hofmann WJ. Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK506 primary immunosuppression. Transplant Proc 26: 3111-3113, 1994.
24. Gray MA, Plant S, and Argent BE. cAMP-regulated whole cell chloride currents in pancreatic duct cells. Am J Physiol Cell Physiol 264: C591-C602, 1993.
25. Green RM, Whiting JF, Rosenbluth AB, Beier D, and Gollan JL. Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphatase activity. Am J Physiol Gastrointest Liver Physiol 267: G1094-G1100, 1994.
26. Hamill OP, Marty A, Neher A, Sakmann B, and Sigworth EJ. Improved patch clamp techniques for high resolution recording from cells and cell-free patches. Pflügers Arch 391: 85-100, 1981.
27. Hamm S, Rudel R, and Brinkmeier H. Excitatory sodium currents of NH15-CA2 neuroblastoma X glioma hybrid cells are differently affected by interleukin-2 and interleukin-1 beta. Pflügers Arch 433: 160-165, 1996.
28. Hayashida K, Kitamura T, Gorman DM, Arai KI, Yokota T, and Miyajima A. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 87: 9655-9659, 1990.
29. Ichikawa N, Taniguchi A, Akama H, Ishiguro H, Kurihara T, Terai C, Hara M, and Kashiwazaki S. Sclerosing cholangitis associated with hypereosinophilic syndrome. Intern Med 36: 561-564, 1997.
30. Ishii M, Vroman B, and LaRusso NF. Isolation and morphological characterization of bile duct epithelial cells from normal rat liver. Gastroenterology 97: 1236-1247, 1989.
31. Klatskin G and Conn HO. Primary biliary cirrhosis. In: Histopathology of the Liver. New York: Oxford Univ., 1993, p. 189-200.
32. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, Bitter-Suermann D, Prellwitz W, and Meyer zum Buschenfelde KH. Biliary adenocarcinoma. Characterization of three new human tumor cell lines. J Hepatol 1: 579-596, 1985.
33. Krams SM, Cao S, Hayashi M, Villanueva JC, and Martinez OM. Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 80: 311-320, 1996.
34. Krouse ME, Hagiwara G, Chen J, Lewiston NJ, and Wine JJ. Ion channels in normal human and cystic fibrosis sweat gland cells. Am J Physiol Cell Physiol 257: C129-C140, 1989.
35. 2+ current by IL-1beta in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 276: H141-H148, 1999.
36. Mahanty S and Nutman TB. The biology of interleukin-5 and its receptor. Cancer Invest 11: 624-634, 1993.
37. Marbet UA, Shefer S, and Leevy CM. Studies of the influence of immunological and serological factors from patients with cholestasis due to alcoholic or viral hepatitis on biliary function in the rat. Eur J Clin Invest 14: 346-353, 1984.
38. Martinez OM, Villanueva JC, Gershwin ME, and Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 21: 113-119, 1995.
39. McGill JM, Basavappa S, and Fitz JG. Characterization of high-conductance anion channels in rat bile duct epithelial cells. Am J Physiol Gastrointest Liver Physiol 262: G703-G710, 1992.
40. - channels in bile duct epithelial cells through a cAMP-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 266: G731-G736, 1994.
41. McGill JM, Basavappa S, Mangel AW, Shimokura GH, Middleton JP, and Fitz JG. Adenosine triphosphate activates ion permeabilities in biliary epithelial cells. Gastroenterology 107: 236-243, 1994.
42. McGill JM, Gettys TW, Basavappa S, and Fitz JG. GTP-binding proteins regulate high conductance anion channels in rat bile duct epithelial cells. J Membr Biol 133: 253-261, 1993.
43. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 181: 257-266, 1997.
44. Mui ALF, Wakao H, Harada N, O'Farrell AM, and Miyajima A. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STATS. J Leukoc Biol 57: 799-803, 1995.
45. Nakamura A, Yamazaki K, Suzuki K, and Sato S. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis. Am J Gastroenterol 92: 2245-2249, 1997.
46. Paradis K, Le ONL, Russo P, St-Cyr M, Fournier H, and Bu D. Characterization and response to interleukin 1 and tumor necrosis factor of immortalized murine biliary epithelial cells. Gastroenterology 109: 1308-1315, 1995.
47. Reynoso-Paz S, Coppel RL, Mackay IR, Bass NM, Ansari AA, and Gershwin ME. The immunobiology of bile and biliary epithelium. Hepatology 30: 351-357, 1999.
48. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, and Tsui LC. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073, 1989.
49. Roberts SK, Ludwig J, and LaRusso NF. The pathobiology of biliary epithelia. Gastroenterology 112: 269-279, 1997.
50. Rommens JM, Iannuzzi MC, Kerem BS, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui LC, and Collins FS. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059-1065, 1989.
51. Rutenburg AM, Kim H, Fischbein JW, Hanker JS, Wasserkrug HL, and Seligman AM. Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. J Histochem Cytochem 17: 517-526, 1969.
52. 2+ signaling in human neutrophil granulocytes. Eur J Immunol 29: 897-904, 1999.
53. 2+ current in adult rat ventricular myocytes. Am J Physiol Heart Circ Physiol 272: H2591-H2598, 1997.
54. Seto D, Kar S, and Quirion R. Evidence for direct and indirect mechanisms in the potent modulatory action of interleukin-2 on the release of acetylcholine in rat hippocampal slices. Br J Pharmacol 120: 1151-1157, 1997.
55. Shoemaker RL, Frizzell RA, Dwyer TM, and Farley JM. Single chloride channel currents from canine tracheal epithelial cells. Biochim Biophys Acta 858: 235-242, 1986.
56. St-Pierre MV, Schlenker T, Dufour JFJ, Jefferson DM, Fitz JG, and Arias IM. Stimulation of cyclic guanosine monophosphate production by natriuretic peptide in human biliary cells. Gastroenterology 114: 782-790, 1998.
57. 2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J Biol Chem 270: 2387-2394, 1995.
58. Takatsu K, Takaki S, and Hitoshi Y. Interleukin-5 and its receptor system: implications in the immune system and inflammation. Adv Immunol 57: 145-190, 1994.
59. Tavernier J, Devos R, Cornells S, Tuypens T, Van Der Heyden J, Fiers W, and Plaetinck G. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a α chain shared with the receptor for GM-CSF. Cell 66: 1175-1184, 1991.
60. Tietz PS, Alpini G, Pham LD, and LaRusso NF. Somatostatin inhibits secretin-induced ductal hypercholeresis and exocytosis by cholangiocytes. Am J Physiol Gastrointest Liver Physiol 269: G110-G118, 1995.
61. Tominaga A, Matsumoto M, Harada N, Takahashi T, Kikuchi Y, and Takatsu K. Molecular properties and regulation of mRNA expression for murine T cell-replacing factor/IL-5. J Immunol 140: 1175-1181, 1988.
62. Trauner M, Meier PJ, and Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 339: 1217-1227, 1998.
63. Valente AI, Pinto HC, Ramalho F, Cabrita PF, Catarino C, Serejo F, Baptista A, Saragoca A, Bordalo O, and Moura MC. Idiopathic hypereosinophilic syndrome presenting as cholestatic liver disease. Eur J Gastroenterol Hepatol 9: 815-817, 1997.
64. Whiting JF, Green RM, Rosenbluth AB, and Gollan JL. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology 22: 1273-1278, 1995.
65. Wright ED, Frenkiel S, Al-Ghamdi K, Ghaffar O, Small P, Troutt T, Tavernier J, and Hamid Q. Interleukin-4, interleukin-5, and granulocyte-macrophage colony-stimulating factor receptor expression in chronic sinusitis and response to topical steroids. Otolaryngol Head Neck Surg 118: 490-495, 1998.
66. Yamazaki K, Nakadate I, Suzuki K, Sato S, and Masuda T. Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol 91: 516-522, 1996.
67. Yang Y, Raper SE, Cohn JA, Engelhardt JF, and Wilson JM. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci USA 90: 4601-4605, 1993.
68. Zund G, Madara JL, Dzus AL, Awtrey CS, and Colgan SP. Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion. J Biol Chem 271: 7460-7464, 1996.